AlphaCore Capital’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
Other funds holding CL
AlphaCore Capital's CL Position: Q2 2026 in Review
AlphaCore Capital increased its Colgate-Palmolive (CL) stake by 78% in Q2 2026, buying an estimated $1.04M and bringing the position to 27,185 shares worth $2.49M. The position accounts for 0.05% of the portfolio, ranked #274.
AlphaCore Capital first reported a position in CL in Q2 2022 and has held it in 17 quarters since. 2,023 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- AlphaCore Capital held 27,185 shares of Colgate-Palmolive worth $2.49M as of Q2 2026.
- AlphaCore Capital bought 11,900 Colgate-Palmolive shares in Q2 2026, an estimated $1.04M.
- Colgate-Palmolive made up 0.05% of AlphaCore Capital's portfolio in Q2 2026, its #274 holding.
- AlphaCore Capital first reported a position in Colgate-Palmolive in Q2 2022 and has held it in 17 quarters since.
- 2,023 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on AlphaCore Capital's 13F filing for Q2 2026, filed 6 Aug 2026.